Investing

Thursday's Top Analyst Upgrades and Downgrades: Baker Hughes, BioMarin, Cisco, Haliburton, Macy’s, Schlumberger, Sherwin-Williams and More

Axalta Coating Systems Ltd. (NYSE: AXTA): Citigroup’s downgrade to Neutral from Buy came with a price target cut to $32 from $39. Shares last closed at $29.07, and the consensus price target is $38.06.

Baker Hughes Co. (NYSE: BKR): RBC Capital Markets resumed coverage with an Outperform rating and a $31 price target. Shares closed at $22.71, and the consensus price target is $28.25.

Blade Air Mobilty Inc. (NASDAQ: BLDE): JPMorgan initiated coverage with an Overweight rating and a $16 price target. The shares have a 52-week range of $6.41 to $19.88, which compares to Wednesday’s close at $8.79.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): upgraded the stock to Buy from Hold and raised the price target to $96 from $86. That is less than the $110.28 consensus target but above Wednesday’s close at $76.70.

Cisco Systems Inc. (NASDAQ: CSCO): Morgan Stanley downgraded is to Equal Weight from Overweight and raised the price target to $59 from $57. Shares last closed at $58.68. The consensus price target is $59.52.

Haliburton Co. (NYSE: HAL): RBC Capital Markets resumed coverage with an Outperform rating and a $27 price target. Shares closed most recently at $19.35, and they have traded as high as $25.00 in the past year.


Humana Inc. (NYSE: HUM): Barclays resumed coverage with an Overweight rating and a $500 price target. The stock closed most recently at $413.50 a share and has a consensus price target of $487.22.

Kimberly-Clark Corp. (NYSE: KMB): HSBC Securities initiated coverage with a Hold rating and a $131 price target. The $139.69 consensus target is below Wednesday’s close at $141.49.

Leslie’s Inc. (NASDAQ: LESL): Stifel started it with a Buy rating and a $28 price target. Shares most recently closed at $24.25, and they have a consensus price target of $32.64.

Macy’s Inc. (NYSE: M): Cowen raised its Market Perform rating to Outperform, and it also hiked the price target to $27 from $23. Shares last closed at $21.23, and the consensus target price is $22.46.